Search

Search Constraints

You searched for: Author/Creator Angelou, Anastasios

Search Results

1. KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases. Issue 11 (November 2019)

3. Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?. (20th October 2021)

9. Monocarboxylate transporter 4 as a prognostic biomarker in patients with colorectal cancer and liver metastases. (2016)